The 62nd American Society of Hematology (ASH) provides an invaluable educational experience and the opportunity to review thousands of scientific abstracts highlighting updates on the most critical topics in hematology. Evidera will be presenting a poster at the virtual meeting titled, “Patient-Reported Experiences During and Following Treatment with Belantamab Mafodotin (Belamaf) for Relapsed/Refractory Multiple Myeloma (RRMM) in the DREAMM-2 Study.” Authors include: Eliason L, Correll J, Martin M, Cardellino A, Opalinska J, Piontek T, Gorsh B, Sapra S, Popat R
